Black Barn Capital Partners LP Roivant Sciences Ltd. Transaction History
Black Barn Capital Partners LP
- $1.13 Trillion
- Q2 2024
A detailed history of Black Barn Capital Partners LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Black Barn Capital Partners LP holds 3,100,000 shares of ROIV stock, worth $34.8 Million. This represents 2.91% of its overall portfolio holdings.
Number of Shares
3,100,000
Previous 1,900,594
63.11%
Holding current value
$34.8 Million
Previous $20 Billion
63.57%
% of portfolio
2.91%
Previous 11.32%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
307Shares Held
497MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$800 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$775 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$748 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$397 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$329 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.9B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...